Financial Counselors Inc’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-24,817
| Closed | -$353K | – | 602 |
|
|
2024
Q3 | $353K | Sell |
24,817
-305
| -1% | -$4.34K | 0.01% | 483 |
|
|
2024
Q2 | $325K | Sell |
25,122
-253
| -1% | -$3.27K | 0.01% | 471 |
|
|
2024
Q1 | $352K | Sell |
25,375
-158
| -0.6% | -$2.2K | 0.01% | 466 |
|
|
2023
Q4 | $364K | Sell |
25,533
-126
| -0.5% | -$1.8K | 0.01% | 448 |
|
|
2023
Q3 | $397K | Sell |
25,659
-40
| -0.2% | -$619 | 0.01% | 424 |
|
|
2023
Q2 | $404K | Sell |
25,699
-57
| -0.2% | -$896 | 0.01% | 390 |
|
|
2023
Q1 | $424K | Sell |
25,756
-191
| -0.7% | -$3.14K | 0.01% | 383 |
|
|
2022
Q4 | $405K | Sell |
25,947
-85
| -0.3% | -$1.33K | 0.01% | 390 |
|
|
2022
Q3 | $338K | Sell |
26,032
-117
| -0.4% | -$1.52K | 0.01% | 400 |
|
|
2022
Q2 | $367K | Sell |
26,149
-1,687
| -6% | -$23.7K | 0.01% | 397 |
|
|
2022
Q1 | $399K | Sell |
27,836
-542
| -2% | -$7.77K | 0.01% | 386 |
|
|
2021
Q4 | $387K | Sell |
28,378
-406
| -1% | -$5.54K | 0.01% | 393 |
|
|
2021
Q3 | $471K | Sell |
28,784
-66
| -0.2% | -$1.08K | 0.01% | 379 |
|
|
2021
Q2 | $486K | Sell |
28,850
-492
| -2% | -$8.29K | 0.01% | 376 |
|
|
2021
Q1 | $536K | Sell |
29,342
-88
| -0.3% | -$1.61K | 0.01% | 360 |
|
|
2020
Q4 | $536K | Sell |
29,430
-105
| -0.4% | -$1.91K | 0.01% | 356 |
|
|
2020
Q3 | $527K | Sell |
29,535
-265
| -0.9% | -$4.73K | 0.02% | 339 |
|
|
2020
Q2 | $534K | Sell |
29,800
-63
| -0.2% | -$1.13K | 0.02% | 352 |
|
|
2020
Q1 | $453K | Sell |
29,863
-276
| -0.9% | -$4.19K | 0.02% | 319 |
|
|
2019
Q4 | $595K | Sell |
30,139
-186
| -0.6% | -$3.67K | 0.02% | 331 |
|
|
2019
Q3 | $522K | Sell |
30,325
-55
| -0.2% | -$947 | 0.02% | 340 |
|
|
2019
Q2 | $538K | Sell |
30,380
-331
| -1% | -$5.86K | 0.02% | 332 |
|
|
2019
Q1 | $626K | Buy |
+30,711
| New | +$626K | 0.03% | 312 |
|